Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

Conditions

• Degenerative Joint Disease of Shoulder

Eligibility Criteria

Sex

ALL

Age

30 Years - 85 Years

Healthy Volunteers

Not accepted

Interventions

• Cryoneurolysis — DEVICE
  Cryoneurolysis of the suprascapular nerve
• No cryoneurolysis — OTHER
  Control Group

Study Details

The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).

Key Dates

Start date

Jul 30, 2025

Status verified

Aug 2025

Primary completion

Jul 31, 2026

Completion

Aug 31, 2026

Study Design

Enrollment

20 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Active Comparator: Control
  Those that do not receive cryoneurolysis of the suprascapular nerve prior to RTSA
• Experimental: Intervention
  Those that do receive cryoneurolysis of the suprascapular nerve prior to RTSA

Primary Outcome Measure

The primary endpoint for the primary objective would be decreased opioid utilization in the post-operative period after a reverse total shoulder arthroplasty (RTSA) as measured by Morphine Milligram Equivalents (MME). [ Time Frame: 90 days ]

Central Contacts

• Jeff Neumann, PA-C
  972-503-9495
  [email protected]

Locations (1)

Find similar trials in Rockwall, TX